ADAR1 Capital Management »

Belite Bio shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.4M 40k 159.96

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Belite Bio

RA Capital Management
Rtw Investments
Vestal Point Capital
Soleus Capital Management
Eventide Asset Management
Marshall Wace
UBS Group
Perceptive Advisors
Goldman Sachs Group
ADAR1 Capital Management
Millennium Management
State Street Corporation
Citadel Advisors
Geode Capital Management
Jpmorgan Chase & Co

View all funds holding Belite Bio